Patients with acromegaly, a rare disorder caused by chronic hypersecretion of growth hormone (GH) and consequent elevation of insulin-like growth factor-1 (IGF-1), are exposed to hormones with well-established mitogenic and anti-apoptotic effects that place them at increased risk for malignancy. The gene discussed is IGF1; the disease is acromegaly.